These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7864905)
1. Isolation of Epstein-Barr-virus-transformed lymphocytes producing IgG class monoclonal antibodies using a magnetic cell separator (MACS): preparation of thyroid-stimulating IgG antibodies from patients with Graves' disease. Li H; Akamizu T; Okuda J; Sugawa H; Matsuda F; Tsubata T; Mori T Biochem Biophys Res Commun; 1995 Feb; 207(3):985-93. PubMed ID: 7864905 [TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs. Akamizu T; Matsuda F; Okuda J; Li H; Kanda H; Watanabe T; Honjo T; Mori T J Immunol; 1996 Oct; 157(7):3148-52. PubMed ID: 8816426 [TBL] [Abstract][Full Text] [Related]
3. Human immunoglobulin G autoantibodies to the thyrotropin receptor from Epstein-Barr virus-transformed B lymphocytes: characterization by immunoprecipitation with recombinant antigen and biological activity. Morgenthaler NG; Kim MR; Tremble J; Huang GC; Richter W; Gupta M; Scherbaum WA; McGregor AM; Banga JP J Clin Endocrinol Metab; 1996 Sep; 81(9):3155-61. PubMed ID: 8784060 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection. Yokoyama N; Izumi M; Katamine S; Nagataki S J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934 [TBL] [Abstract][Full Text] [Related]
5. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen. Baker JR; Saunders NB; Kaulfersch W; Burman KD J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus reactivation in peripheral B lymphocytes induces IgM-type thyrotropin receptor autoantibody production in patients with Graves' disease. Nagata K; Hayashi K; Kumata K; Satoh Y; Osaki M; Nakayama Y; Kuwamoto S; Ichihara Y; Okura T; Matsuzawa K; Miake J; Fukata S; Imamura T Endocr J; 2023 Jun; 70(6):619-627. PubMed ID: 36908137 [TBL] [Abstract][Full Text] [Related]
8. Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation. Steinitz M; Koskimies S; Klein G; Mäkelä O J Clin Lab Immunol; 1979 Apr; 2(1):1-7. PubMed ID: 95800 [TBL] [Abstract][Full Text] [Related]
9. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease. Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404 [TBL] [Abstract][Full Text] [Related]
10. Variable regions of Ig heavy chain genes encoding antithyrotropin receptor antibodies of patients with Graves' disease. Shin EK; Akamizu T; Matsuda F; Sugawa H; Fujikura J; Mori T; Honjo T J Immunol; 1994 Feb; 152(3):1485-92. PubMed ID: 8301147 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity and diversity of IgM and IgG lupus anticoagulants in an individual with systemic lupus erythematosus. Nakamura N; Azuma C; Akamizu T; Sugawa H; Matsuda F; Mitsuda N; Honjo T; Mori T; Yamaji K Biochem Biophys Res Commun; 1994 Sep; 203(3):1789-94. PubMed ID: 7945329 [TBL] [Abstract][Full Text] [Related]
12. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies. Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965 [TBL] [Abstract][Full Text] [Related]
13. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus. Nakamura M; Burastero SE; Ueki Y; Larrick JW; Notkins AL; Casali P J Immunol; 1988 Dec; 141(12):4165-72. PubMed ID: 2848890 [TBL] [Abstract][Full Text] [Related]
14. Estradiol Affects Epstein-Barr Virus Reactivation-Induced Thyrotropin Receptor Antibody and Immunoglobulin Production in Graves' Disease Patients and Healthy Controls. Hara S; Nagata K; Kumata K; Matsushita M; Kuwamoto S; Kato M; Hayashi K Viral Immunol; 2018 Sep; 31(7):486-491. PubMed ID: 30133352 [TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus. Brown NA; Miller G J Immunol; 1982 Jan; 128(1):24-9. PubMed ID: 6274955 [TBL] [Abstract][Full Text] [Related]
16. [An investigation on the percentages of TRAb-producing cells in Graves disease]. Jia W; An Z; Chen D; Wei S Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):100-3. PubMed ID: 15600195 [TBL] [Abstract][Full Text] [Related]
17. [Obtention of a heterohybridoma for production of type IgM monoclonal antibodies against the D antigen of the Rh system]. León-González G; Cruz C Invest Clin; 2007 Mar; 48(1):57-67. PubMed ID: 17432544 [TBL] [Abstract][Full Text] [Related]
18. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies. Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition. Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515 [TBL] [Abstract][Full Text] [Related]
20. Construction of human monoclonal antibodies against rabies NS-protein antigen by Epstein-Barr virus transformation. Gebauer W; Lindl T Arzneimittelforschung; 1990 Jun; 40(6):718-22. PubMed ID: 2168706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]